FDA NDA · NDA050741

DUAC

Sponsor: STIEFEL

What this page does not claim

A drug page is a reference view of public FDA data (Drugs@FDA), reproduced as published. SPEQ is not affiliated with the FDA, adds no interpretation to the record, and nothing here is medical, legal, or regulatory advice.

APPLICATION
NDA050741
TYPE
NDA
ORIGINAL APPROVAL
2002-08-26
LATEST ACTION
2026-10-07
ROUTE
TOPICAL
DOSAGE FORM
GEL
MARKETING STATUS
Prescription

Products

DUAC · ReferencePrescription
BENZOYL PEROXIDE 5%, CLINDAMYCIN PHOSPHATE 1.2% · GEL · TOPICAL

Approval history

2026-10-07Labeling · Supplement 26 · standard — Letter ↗AP
2015-04-15Labeling · Supplement 24 · standard — Label ↗AP
2014-10-15Manufacturing (CMC) · Supplement 23 · standardAP
2014-05-19Manufacturing (CMC) · Supplement 22 · standardAP
2013-12-27Labeling · Supplement 21 · standard — Label ↗AP
2013-06-07Labeling · Supplement 20 · standard — Letter ↗AP
2012-11-14Manufacturing (CMC) · Supplement 18 · standardAP
2011-12-21Labeling · Supplement 19 · standard — Label ↗AP
2010-11-08Labeling · Supplement 15 · unknown — Letter ↗AP
2008-07-22Labeling · Supplement 11 · standard — Label ↗AP
2003-11-17Manufacturing (CMC) · Supplement 4 · standard — Letter ↗AP
2003-10-20Labeling · Supplement 3 · standard — Label ↗AP
2002-08-26Type 4 - New Combination · Original · standard — Review ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. Browse every approval SPEQ tracks →